25th week of 2020 patent applcation highlights part 11 |
Patent application number | Title | Published |
20200188409 | USE OF MIRTAZAPINE IN THE TREATMENT OF INFLAMMATORY DISORDERS, AUTOIMMUNE DISEASE AND PBC | 2020-06-18 |
20200188410 | CXCR7 INHIBITORS FOR THE TREATMENT OF CANCER | 2020-06-18 |
20200188411 | FULVESTRANT FORMULATIONS | 2020-06-18 |
20200188412 | ACTIVE ESTER DERIVATIVES OF TESTOSTERONE, COMPOSITIONS AND USES THEREOF | 2020-06-18 |
20200188413 | METHODS OF REDUCING RISK OF PRETERM BIRTH | 2020-06-18 |
20200188414 | FORMULATIONS OF DEOXYCHOLIC ACID AND SALTS THEREOF | 2020-06-18 |
20200188415 | METHODS FOR THE SEPARATION AND DETECTION OF AN OXYSTEROL | 2020-06-18 |
20200188416 | METHODS OF TREATING ADVANCED PROSTATE CANCER | 2020-06-18 |
20200188417 | IN-VIAL DEPOSITION OF A STABLE, STERILE AND CRYSTALLINE O-ACETYL SALICYLIC ACID (ASPIRIN) | 2020-06-18 |
20200188418 | ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | 2020-06-18 |
20200188419 | COMBINATION FORMULATION OF TWO ANTIVIRAL COMPOUNDS | 2020-06-18 |
20200188420 | METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS | 2020-06-18 |
20200188421 | MATERNAL VITAMIN B12 ADMINISTRATION FOR THE PREVENTION OF INCREASED ADIPOSITY, OVERWEIGHT OR OBESITY IN THE OFFSPRING ESPECIALLY OFFSPRING OVERWEIGHT AND/OR OBESE MOTHERS | 2020-06-18 |
20200188422 | INHIBITION OF EXPANSION AND FUNCTION OF PATHOGENIC AGE-ASSOCIATED B CELLS AND USE FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASE | 2020-06-18 |
20200188423 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE | 2020-06-18 |
20200188424 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROTIC DISEASES | 2020-06-18 |
20200188425 | FOOD AND/OR FEED COMPOSITIONS FOR PREVENTING AND TREATING INFLAMMATORY DISEASES | 2020-06-18 |
20200188426 | WOUND MANAGEMENT METHOD | 2020-06-18 |
20200188427 | REDUCTION OF ADVANCED GLYCATION ENDPRODUCTS FROM BODILY FLUIDS | 2020-06-18 |
20200188428 | Substances Containing AuCs and Preparation Method and Use Thereof | 2020-06-18 |
20200188429 | Novel Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor | 2020-06-18 |
20200188430 | THERAPEUTIC METAL COMPLEXES AND LIGANDS AND METHODS OF MAKING AND USING THE SAME | 2020-06-18 |
20200188431 | GLUTAMINE DEHYDROGENASE INHIBITORS FOR USE IN MUSCLE REGENERATION | 2020-06-18 |
20200188432 | CS1 TARGETED CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS FOR TREATMENT OF AL AMYLOIDOSIS | 2020-06-18 |
20200188433 | aNK AND IL-12 COMPOSITIONS AND METHODS | 2020-06-18 |
20200188434 | A CELL COMPRISING A CHIMERIC ANTIGEN RECEPTOR (CAR) | 2020-06-18 |
20200188435 | T CELL COMPOSITIONS WITH IMPROVED PHENOTYPIC PROPERTIES | 2020-06-18 |
20200188436 | Compositions and Methods for Cancer Immunotherapy | 2020-06-18 |
20200188437 | CANCER ANTIGEN SPECIFIC CYTOTOXIC T CELL | 2020-06-18 |
20200188438 | IMMUNOTHERAPY WITH B*08 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 2020-06-18 |
20200188439 | TREATMENT OF MULTIPLE SCLEROSIS WITH ADIPOSE-DERIVED STEM CELLS | 2020-06-18 |
20200188440 | METHODS OF INHIBITING AGING AND TREATING AGING-RELATED DISORDERS | 2020-06-18 |
20200188441 | METHODS AND COMPOSITIONS FOR REDUCING CORNEAL ENDOTHELIAL CELL LOSS | 2020-06-18 |
20200188442 | COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE (PD) AND RELATED DISORDERS | 2020-06-18 |
20200188443 | COMPOSITIONS AND METHODS FOR OBTAINING ORGANOIDS | 2020-06-18 |
20200188444 | HEPATOCYTES AND HEPATIC NON-PARENCHYMAL CELLS, AND METHODS FOR PREPARATION THEREOF | 2020-06-18 |
20200188445 | Methods for Protecting a Parathyroid | 2020-06-18 |
20200188446 | Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem Cells | 2020-06-18 |
20200188447 | COSMETIC OR DERMATOLOGICAL PREPARATION CONTAINING AN AQUEOUS AND A LIPOPHILIC FISH EGG EXTRACT | 2020-06-18 |
20200188448 | CORAL COMPOSITE EXTRACT, COMPOSITION INCLUDING THE SAME AND METHOD OF PRODUCING THE SAME | 2020-06-18 |
20200188449 | Compositions and Methods for Treating Chronic Fatigue Syndrome and Related Disorders | 2020-06-18 |
20200188450 | FECAL MICROBIOTA FOR TREATING PATIENTS UNDERGOING A HEMATOPOIETIC STEM CELL TRANSPLANT | 2020-06-18 |
20200188451 | OXALOBACTER FORMIGENES (Of)-DERIVED FACTORS FOR THE TREATMENT OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS | 2020-06-18 |
20200188452 | PURIFIED ANTHELMINTIC COMPOSITIONS AND RELATED METHODS | 2020-06-18 |
20200188453 | METHOD OF A LACTOBACILLUS PLANTARUM TWK10 COMPOSITION FOR IMPROVING INFLAMMATION AFTER EXERCISE | 2020-06-18 |
20200188454 | USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT AT LEAST ONE OF POSTNATAL DEPRESSION AND POSTNATAL ANXIETY | 2020-06-18 |
20200188455 | TUBE FEED FORMULATIONS AND METHODS FOR USING SAME | 2020-06-18 |
20200188456 | ANELLOVIRUS COMPOSITIONS AND METHODS OF USE | 2020-06-18 |
20200188457 | RED SEAWEED EXTRACTS, FORMULATIONS AND ANTI-MICROBIAL USES THEREOF | 2020-06-18 |
20200188458 | METHOD OF TREATING ALIMENTARY CANAL CONDITIONS | 2020-06-18 |
20200188459 | PROCESS FOR PREPARING METABOLIZED CONDITIONED GROWTH MEDIA | 2020-06-18 |
20200188460 | PHARMACEUTICAL COMPOSITION FOR WOUND HEALING COMPRISING CERIPORIA LACERATA CULTURE MEDIUM | 2020-06-18 |
20200188461 | MANUFACTURING METHODS, COMPOSITIONS, AND MEDICAL APPLICATIONS OF ORALLY ADMINISTERED CANNABIS PHARMACEUTICALS USING REPRESENTATIVE/TOTAL/COMPLETE CANNABIS EXTRACTIONS (CANNABIS INFUSED PILLS) | 2020-06-18 |
20200188462 | Method of Drying Botanicals | 2020-06-18 |
20200188463 | DEVELOPMENT OF A STANDARDIZED AND EFFECT-OPTIMIZED HERBAL EXTRACT OF WEDELIA CHINENSIS AND ITS USE FOR TREATING DISEASE | 2020-06-18 |
20200188464 | COMPOSITION FOR PROTECTING LIVER COMPRISING DANDELION EXTRACT AND LEMON BALM EXTRACT | 2020-06-18 |
20200188465 | TREATMENT OF CYTOKINE RELEASE SYNDROME BY DECREASING LEVEL OF PROINFLAMMATORY CYTOKINE | 2020-06-18 |
20200188466 | COMPOSITIONS OF SCHISANDRA EXTRACTS AND METHODS THEREOF | 2020-06-18 |
20200188467 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF "PLAQUES AND TANGLES" IN HUMANS AND ANIMALS | 2020-06-18 |
20200188468 | A COATED COSTUS COMPOSITION ENRICHED WITH TRITERPENOIDS AND A METHOD OF PREPARATION OF THE SAME | 2020-06-18 |
20200188469 | COMPOUNDS AND METHODS FOR INHIBITING CDK5 ALLEVIATE CARDIAC PHENOTYPES IN TIMOTHY SYNDROME AND RELATED CONDITIONS | 2020-06-18 |
20200188470 | METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE | 2020-06-18 |
20200188471 | APPLICATION OF SELECTIVE TNFR1 ANTAGONIST PEPTIDE SN10 IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS | 2020-06-18 |
20200188472 | CONJUGATES FOR IMMUNOTHERAPY | 2020-06-18 |
20200188473 | COMBINATION THERAPY FOR CANCER | 2020-06-18 |
20200188474 | PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS | 2020-06-18 |
20200188475 | REAGENTS FOR INDUCING AN IMMUNE RESPONSE | 2020-06-18 |
20200188476 | ANTI-MICROBIAL AGENT-POLYMER CONJUGATES AND METHODS OF USE THEREOF | 2020-06-18 |
20200188477 | A MEDICAMENT FOR THE TREATMENT OF DISEASES BY BIOFILM FORMING MICROORGANISMS | 2020-06-18 |
20200188478 | PRE-MIXED, READY TO USE VANCOMYCIN COMPOSITIONS | 2020-06-18 |
20200188479 | APPARATUS AND METHODS FOR ADMINISTRATION OF A NAUSEOGENIC COMPOUND FROM A DRUG DELIVERY DEVICE | 2020-06-18 |
20200188480 | NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | 2020-06-18 |
20200188481 | Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof | 2020-06-18 |
20200188482 | TARGETING GAMMA-DELTA T CELLS IN OBESITY AND CACHEXIA | 2020-06-18 |
20200188484 | CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES | 2020-06-18 |
20200188485 | AMYLIN ANALOGUES | 2020-06-18 |
20200188486 | SUCROSE ACETATE ISOBUTYRATE-BASED COMPOSITIONS, METHODS AND USES THEREOF | 2020-06-18 |
20200188487 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST HUMAN INSULIN A21G AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION | 2020-06-18 |
20200188488 | HIGH CONCENTRATED PROTEIN COMPOSITIONS FOR PREVENTING TISSUE ADHESION | 2020-06-18 |
20200188489 | LOW CONCENTRATED PROTEIN COMPOSITIONS FOR PREVENTING TISSUE ADHESION | 2020-06-18 |
20200188490 | HYALURONIC ACID CONTAINING COMPOSITIONS FOR PREVENTION OF THE FORMATION OF POST-SURGICAL SCARS AND POST-SURGICAL ADHESIONS | 2020-06-18 |
20200188491 | Therapeutic Agent For Diseases Associated With Abnormalities In Dystroglycan Sugar Chain Modification And Method For Assaying Associated Enzyme | 2020-06-18 |
20200188492 | METHODS FOR INCREASING INTRACELLULAR ACTIVITY OF HSP70 | 2020-06-18 |
20200188493 | METHOD TO IMPROVE SAFETY AND EFFICACY OF ANTI-CANCER THERAPY | 2020-06-18 |
20200188494 | HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE | 2020-06-18 |
20200188495 | Compositions and Methods for Generating Tick Immunity | 2020-06-18 |
20200188496 | UNIVERSAL CANCER VACCINES AND METHODS OF MAKING AND USING SAME | 2020-06-18 |
20200188497 | TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS | 2020-06-18 |
20200188498 | TARGETED GENE DISRUPTION METHODS AND IMMUNOGENIC COMPOSITIONS | 2020-06-18 |
20200188499 | DRIED COMPOSITION | 2020-06-18 |
20200188500 | VACCINE COMPRISING CLOSTRIDIUM TOXOIDS | 2020-06-18 |
20200188501 | BACTERIAL VACCINE COMPONENTS AND USES THEREOF | 2020-06-18 |
20200188502 | IMMUNOGENIC COMPOSITION | 2020-06-18 |
20200188503 | DNA VACCINE AGAINST VIRUS OF YELLOW FEVER | 2020-06-18 |
20200188504 | HEPATITIS C VIRUS GENE SEQUENCES AND METHODS OF USE THEREFOR | 2020-06-18 |
20200188505 | UNIVERSAL INFLUENZA VACCINE | 2020-06-18 |
20200188506 | VECTORS FOR ELICITING IMMUNE RESPONSES TO NON-DOMINANT EPITOPES IN THE HEMAGGLUTININ (HA) PROTEIN | 2020-06-18 |
20200188507 | INFLUENZA VIRUS VACCINE AND METHOD OF MAKING | 2020-06-18 |
20200188508 | PORCINE EPIDEMIC DIARRHEA VIRUS S PROTEIN AND SUBUNIT VACCINE THEREOF AS WELL AS METHOD FOR PREPARING SUBUNIT VACCINE AND APPLICATION THEREOF | 2020-06-18 |
20200188509 | ORF VIRUS-BASED PLATFORM FOR VACCINE DELIVERY | 2020-06-18 |